The company confirmed the publication of its successful clinical case series in Frontiers in Immunology, a peer-reviewed scientific journal, and received confirmation from the U.S. Food and Drug ...
A small prospective, double-blind study in children with IgE-mediated cow’s milk allergy (CMA) found that heated cow’s milk ...
The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate ...
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915) Patients with stage IIIB-IVM1c unresectable ...
This was a double-blind, phase III trial designed to show the noninferiority of a DEX-free regimen (olanzapine, palonosetron, and fosaprepitant [OPF]) compared with the DEX-containing regimen ...
Soleno Therapeutics (SLNO) announced a publication in the peer-reviewed Journal of Clinical Endocrinology and Metabolism. The paper, titled, ...
Neumora Therapeutics (NMRA) announced results from its Phase 1b signal-seeking study of NMRA-511 in people with Alzheimer’s disease agitation.
“Can the blind lead the blind? Shall they not both fall into the pit?” Luke 6:39 While “the blind leading the blind” has become an often-used idiom of incompetency and ineffectiveness, the “randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback